no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Authors Index
|
|
|
|
7 |
S1 |
p. 163-173 |
article |
2 |
Committees
|
|
|
|
7 |
S1 |
p. 8 |
article |
3 |
Copyright
|
|
|
|
7 |
S1 |
p. ii |
article |
4 |
Editorial Board
|
|
|
|
7 |
S1 |
p. i |
article |
5 |
Financial support
|
|
|
|
7 |
S1 |
p. 8 |
article |
6 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 18 |
article |
7 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 21 |
article |
8 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 19-20 |
article |
9 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 27-28 |
article |
10 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 29-30 |
article |
11 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 22 |
article |
12 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 23 |
article |
13 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 24 |
article |
14 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 25-26 |
article |
15 |
Lecture sessions
|
|
|
|
7 |
S1 |
p. 17 |
article |
16 |
NCI-EORTC Symposium on New Drugs in Cancer Therapy
|
Lobbezoo, M.W. |
|
|
7 |
S1 |
p. 6 |
article |
17 |
Opening ceremony
|
|
|
|
7 |
S1 |
p. 15 |
article |
18 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 31-32 |
article |
19 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 33-35 |
article |
20 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 75-77 |
article |
21 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 41-46 |
article |
22 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 36-38 |
article |
23 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 39-40 |
article |
24 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 118-125 |
article |
25 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 91-96 |
article |
26 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 126-133 |
article |
27 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 134-141 |
article |
28 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 47-48 |
article |
29 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 105-113 |
article |
30 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 62-64 |
article |
31 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 72-74 |
article |
32 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 56-57 |
article |
33 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 81-84 |
article |
34 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 71 |
article |
35 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 53-55 |
article |
36 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 60-61 |
article |
37 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 114-117 |
article |
38 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 78-80 |
article |
39 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 65-70 |
article |
40 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 58-59 |
article |
41 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 97-104 |
article |
42 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 85-90 |
article |
43 |
Poster sessions
|
|
|
|
7 |
S1 |
p. 49-52 |
article |
44 |
Preface
|
Pinedo, H.M. |
|
|
7 |
S1 |
p. 5 |
article |
45 |
Special workshop
|
|
|
|
7 |
S1 |
p. 10-11 |
article |
46 |
Special workshop
|
|
|
|
7 |
S1 |
p. 13-14 |
article |
47 |
Special workshop
|
|
|
|
7 |
S1 |
p. 9 |
article |
48 |
Special workshop
|
|
|
|
7 |
S1 |
p. 12 |
article |
49 |
Subject Index
|
|
|
|
7 |
S1 |
p. 143-162 |
article |
50 |
Table of Contents
|
|
|
|
7 |
S1 |
p. iv |
article |
51 |
The EORTC New Drug Development Office (NDDO)
|
van Kalken, C.K. |
|
|
7 |
S1 |
p. 7 |
article |
52 |
Title Page
|
|
|
|
7 |
S1 |
p. iii |
article |